// COMPANY
Frazier Life Sciences
SECTOR VENTURE CAPITALMENTIONS 2LAST SEEN AUGUST 6, 2026
Discussed in
// RECENT MENTIONS
// SIGNALS
2 SIGNALS
01
funding·PitchBook News·AUGUST 6, 2026
“Frazier Life Sciences-backed Attovia Therapeutics raised $289 million in its IPO, building on a record-breaking quarter for the sector.”
Source→02
funding·Lucinda Shen·JULY 23, 2026
“Raised $130M Series B — one of the larger biotech rounds in the issue, led by Frazier Life Sciences with broad institutional participation.”
AI-extracted from podcast / newsletter / paper summaries. May contain errors.